Friday, November 22, 2024
HomeTagsALISCA-Lung1 Phase II

ALISCA-Lung1 Phase II

Puma Biotechnology Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib in Small Cell Lung Cancer

Puma Biotechnology, Inc., a biopharmaceutical company, announced the initiation of its ALISertib in CAncer Phase II trial of alisertib monotherapy for the treatment of...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics